Cyclopentenyl cytosine primes SK-N-BE(2)C neuroblastoma cells for cytarabine toxicity

International Journal of Cancer

Volumn 103, Issue 3, 2003, Pages 387-392

  Bierau, Jörgen ^a   Van Gennip, Albert H ^a   Leen, René ^a   Helleman, Jozien ^a   Caron, Huib N ^a   Van Kuilenburg, André B P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

CTP synthetase; Cyclopentenyl cytosine; Deoxycytidine kinase; I D arabinofuranosyl cytosine; Neuroblastoma

Indexed keywords

1 (4,5 DIHYDROXY 3 HYDROXYMETHYL 2 CYCLOPENTEN 1 YL)CYTOSINE; CASPASE 3; CYTARABINE; CYTIDINE TRIPHOSPHATE; CYTIDINE TRIPHOSPHATE SYNTHASE; DNA; NUCLEOTIDE; SYNTHETASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CANCER CELL CULTURE; CELL CYCLE S PHASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOSTASIS; DNA SYNTHESIS; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CARBON-NITROGEN LIGASES; CELL CYCLE; CELL DIVISION; CYTARABINE; CYTIDINE; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; ENZYME INHIBITORS; HUMANS; NEUROBLASTOMA; PHOSPHORYLATION; TUMOR CELLS, CULTURED;

EID: 0037454759     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10858     Document Type: Article

References (27)

1. Ford H Jr, Cooney DA, Ahluwalia GS, Hao Z, Rommel ME, Hicks L, Dobyns KA, Tomaszewski JE, Johns DG. Cellular pharmacology of cyclopentenyl cytosine in Molt-4 lymphoblasts. Cancer Res 1991;51:3733-40.
2. Verschuur AC, Van Gennip AH, Leen R, Muller EJ, Elzinga L, Voute PA, van Kuilenburg ABP. Cyclopentenyl cytosine inhibits cytidine triphosphate synthetase in paediatric acute non-lymphocytic leukaemia: A promising target for chemotherapy. Eur J Cancer 2000;36:627-35.
3. Kang GJ, Cooney DA, Moyer JD, Kelley JA, Kim HY, Marquez VE, Johns DG. Cyclopentenylcytosine triphosphate. Formation and inhibition of CTP synthetase. J Biol Chem 1989;264:713-8.
4. Gharehbaghi K, Zhen W, Fritzer-Szekeres M, Szekeres T, Jayaram HN. Studies on the antitumor activity and biochemical actions of cyclopentenyl cytosine against human colon carcinoma HT-29 in vitro and in vivo. Life Sci 1999;64:103-12.
5. Yee LK, Allegra CJ, Trepel JB, Grem JL. Metabolism and RNA incorporation of cyclopentenyl cytosine in human colorectal cancer cells. Biochem Pharmacol 1992;43:1587-99.
6. Slingerland RJ, Van Gennip AH, Bodlaender JM, Voute PA, van Kuilenburg ABP. Cyclopentenyl cytosine and neuroblastoma SK-N-BE(2)-C cell line cells. Eur J Cancer 1995;31A:627-31.
7. Slingerland RJ, Van Gennip AH, Bodlaender JM, Voute PA, van Kuilenburg ABP. The effect of cyclopentenyl cytosine on human SK-N-BE(2)-C neuroblastoma cells. Biochem Pharmacol 1995;50:277-9.
8. Agbaria R, Kelley JA, Jackman J, Viola JJ, Ram Z, Oldfield E, Johns DG. Antiproliferative effects of cyclopentenyl cytosine (NSC 375575) in human glioblastoma cells. Oncol Res 1997;9:111-8.
9. Verschuur AC, Van Gennip AH, Leen R, Voute PA, Brinkman J, van Kuilenburg ABP. Cyclopentenyl cytosine increases the phosphorylation and incorporation into DNA of 1-β-D-arabinofuranosyl cytosine in a human T-lymphoblastic cell line. Int J Cancer 2002;98:616-23.
10. Bouffard DY, Momparler LF, Momparler RL. Enhancement of the antileukemic activity of 5-aza-2′-deoxycytidine by cyclopentenyl cytosine in HL-60 leukemic cells. Anticancer Drugs 1994;5:223-8.
11. Bierau J, Van Gennip AH, Helleman J, van Kuilenburg ABP. The cytostatic and differentiation inducing effect of cyclopentenyl cytosine on human neuroblastoma cell lines. Biochem Pharmacol 2001; 62:1099-105.
12. Finklestein JZ, Higgins G, Krivit W, Hammond D. Evaluation of cyclocytidine in children with advanced acute leukemia and solid tumors. Cancer Treat Rep 1979;63:1331-3.
13. Ohno Y, Spriggs D, Matsukage A, Ohno T, Kufe D. Effects of 1-β-D-arabinofuranosylcytosine incorporation on elongation of specific DNA sequences by DNA polymerase beta. Cancer Res 1988;48:1494-8.
14. Hatzis P, Al Madhoon AS, Jullig M, Petrakis TG, Eriksson S, Talianidis I. The intracellular localization of deoxycytidine kinase. J Biol Chem 1998;273:30239-43.
15. Arner ES, Eriksson S. Mammalian deoxyribonucleoside kinases. Pharmacol Ther 1995;67:155-86.
16. Ives DH, Durham JP. Deoxycytidine kinase. 3. Kinetics and allosteric regulation of the calf thymus enzyme. J Biol Chem 1970;245:2285-94.
17. Verschuur AC, Brinkman J, Van Gennip AH, Leen R, Vet RJWM, Evers LM, Voute PA, van Kuilenburg ABP. Cyclopentenyl cytosine induces apoptosis and increases cytarabine-induced apoptosis in a T-lymphoblastic cell-line. Leuk Res 2001;25:891-900.
18. Grem JL, Allegra CJ. Enhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and 1-β-D-arabinofuranosylcytosine by cyclopentenyl cytosine. Cancer Res 1990;50:7279-84.
19. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
20. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res 1987;47:936-42.
21. Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984;22:27-55.
22. Peters GJ, van der Wilt CL, van Moorsel CJ, Kroep JR, Bergman AM, Ackland SP. Basis for effective combination cancer chemotherapy with antimetabolites. Pharmacol Ther 2000;87:227-53.
23. Weinstein HJ, Griffin TW, Feeney J, Cohen HJ, Propper RD, Sallan SE. Pharmacokinetics of continuous intravenous and subcutaneous infusions of cytosine arabinoside. Blood 1982;59:1351-3.
24. Zittoun J, Marquet J, David JC, Maniey D, Zittoun R. A study of the mechanisms of cytotoxicity of Ara-C on three human leukemic cell lines. Cancer Chemother Pharmacol 1989;24:251-5.
25. Morita T, Tsutsui Y, Nishiyama Y, Nakamura H, Yoshida S. Effects of DNA polymerase inhibitors on replicative and repair DNA synthesis in ultraviolet-irradiated HeLa cells. Int J Radiat Biol Relat Stud Phys Chem Med 1982;42:471-80.
26. Wist E. The role of DNA polymerases alpha, beta and gamma in nuclear DNA synthesis. Biochim Biophys Acta 1979;562:62-9.
27. Bierau J, Van Gennip AH, van Kuilenburg ABP. Recovery of SK-N-BE(2)c cells from treatment with cyclopentenyl cytosine. In: Zoref-Shani E, Sperling O, eds. Purine and Pyrimidine Metabolism in Man. vol. X. New York: Kluwer/Plenum, 2000. 277-80.